Modulation of the antigenic phenotype of early‐passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon
- 15 September 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (3) , 539-545
Abstract
We have investigated the relationship between in vitro cultivation of autologous melanoma metastases derived from different patients and their levels of expression of class‐l and‐11 major histocompatibility complex (MHC) antigens and melanoma‐associated antigens (MAAS). Cell cultures were established from 23 individual metastatic melanoma lesions from 10 patients and were tested early after isolation (between 3rd and 10th passages) for both constitutive expression and modulation by recombinant human leukocyte (IFN‐α), fibroblast (IFN‐β) or immune (IFN‐γ) interferon of MHC antigens and MAA. All of the melanoma cell lines displayed altered antigen expression following IFN treatment. While in vitro cultures derived from different individuals varied in both constitutive and IFN‐modified antigenic expression. cultures of autologous metatases derived from the same patient were very similar. In addition, differences in antigenic profile were apparent when early‐passage in vitro cultures were compared with the same melanoma lesion, not established in culture, from which they were derived. The unique de novo and IFN‐modified antigenic phenotype of cultures derived from different patients indicates that the antigenic phenotype displayed by melanoma cultures grown in vitro is genetically determined. The differences found between in vitro cultures and their corresponding in vivo lesions, as well as the antigenic heterogeneity displayed by multiple autologous melanoma lesions in vivo, suggest that the in vivo antigenic phenotype may be determined, at least in part, at an epigenetic level.Keywords
This publication has 25 references indexed in Scilit:
- mAb KUL/05 IDENTIFIES A DENATURATION‐RESISTANT DETERMINANT SHARED BY CLASS II MHC PRODUCTS DR, DQ AND DPInternational Journal of Immunogenetics, 1989
- Multiple epitope recognition: An approach to improved radioimmunodetection of tumor‐associated antigensInternational Journal of Cancer, 1987
- Physiologic Regulation of Class II Major Histocompatibility Complex Gene Expression1986
- Differential Susceptibility to Modulation by Recombinant Immune Interferon of HLA-DR and -DQ Antigens Synthesized by Melanoma COLO 38 CellsHybridoma, 1986
- Regulation of cell proliferation and differentiation by interferonsBiochemical Journal, 1985
- A third polypeptide associated with heavy and light chain subunits of class I HLA antigens in immune interferon‐treated human melanoma cellsEuropean Journal of Immunology, 1985
- Effects of interferon on differentiation of normal and tumor cellsPharmacology & Therapeutics, 1985
- Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cellsCell, 1984
- Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.Proceedings of the National Academy of Sciences, 1982
- Metastasis Results from Preexisting Variant Cells Within a Malignant TumorScience, 1977